NCT06702904

Brief Summary

This clinical trial is designed to assess the effectiveness of advanced neuromodulation techniques in reducing phantom limb pain by improving sensory feedback in bionic prostheses. The study will explore the use of Peripheral Nerve Stimulation to evaluate their impact on pain relief and sensory restoration. The trial aims the development of neuroprostheses that can provide sensory feedback through stimulation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
37mo left

Started Dec 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Dec 2024May 2029

First Submitted

Initial submission to the registry

November 13, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 25, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2029

Last Updated

November 25, 2024

Status Verified

November 1, 2024

Enrollment Period

3.8 years

First QC Date

November 13, 2024

Last Update Submit

November 21, 2024

Conditions

Keywords

NeuromodulationPhantom limb painNeuropathic painNeurostimulationChronic painPeripheral nerve stimulationPNSSpinal cord stimulationSCSDorsal root ganglion stimulationDRGCortical stimulationAmputationNeurotechnologyNeuroprostheticsBCI

Outcome Measures

Primary Outcomes (3)

  • VAS

    The Visual Analog Scale (VAS) is a 10 cm line used to measure pain intensity. One end of the line represents \"no pain,\" while the other end signifies \"worst possible pain.\" The line can be either horizontal or vertical.

    up to 4 months

  • SF-36

    The questionnaire consists of 36 items grouped into eight scales: physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, emotional well-being, and mental health. Each scale ranges from 0 to 100, where 100 represents full health. Higher scores indicate better quality of life, with two summary measures: physical and mental well-being.

    up to months

  • DN 4

    The DN4 (Douleur Neuropathique 4) questionnaire is a diagnostic tool designed to identify neuropathic pain, caused by nerve damage. It includes 10 items divided into two sections. The first part consists of seven questions that assess the patient's pain symptoms, such as burning, tingling, electric shocks, or numbness. The second part involves a clinical examination where the physician tests for reduced sensitivity to touch and pinprick, as well as pain response to light brushing. Each item is scored with 1 point for "Yes" and 0 for "No." A total score of 4 or higher indicates a high probability of neuropathic pain.

    Up to 6 months

Secondary Outcomes (6)

  • Sensory threshold change

    At least three measurements. 1 - First week after implantation, 2 - Up to three months after implantation, 3 - Up to five months after implantation

  • Agency

    Up to 6 months

  • Embodiment

    Up to 6 months

  • Pain detect

    Up to 6 months

  • Hospital Anxiety and Depression Scale (HADS)

    Up to 6 months

  • +1 more secondary outcomes

Other Outcomes (15)

  • Object detection

    Up to 6 months

  • Visual-motor integration

    Up to 4 months

  • Value of sensory discrimination

    Up to once in two weeks

  • +12 more other outcomes

Study Arms (8)

Peripheral nerve stimulation for upper-limb prosthesis

EXPERIMENTAL
Procedure: Peripheral Nerve Stimulation

Peripheral nerve stimulation for lower-limb prosthesis

EXPERIMENTAL
Procedure: Peripheral Nerve Stimulation

Spinal cord stimulation for upper-limb prosthesis

EXPERIMENTAL
Procedure: Spinal cord stimulation

Spinal cord stimulation for lower-limb prosthesis

EXPERIMENTAL
Procedure: Spinal cord stimulation

Dorsal root ganglion stimulation for upper-limb prosthesis

EXPERIMENTAL
Procedure: Dorsal Root Ganglion Stimulation

Experimental: Dorsal root ganglion stimulation for lower-limb prosthesis

EXPERIMENTAL
Procedure: Dorsal Root Ganglion Stimulation

Motor Cortex Stimulation for upper-limb prosthesis

EXPERIMENTAL
Procedure: Motor Cortex Stimulation

Motor Cortex Stimulation for lower-limb prosthesis

EXPERIMENTAL
Procedure: Motor Cortex Stimulation

Interventions

Peripheral Nerve Stimulation (PNS) is a neuromodulation technique used to treat chronic pain. The procedure starts with a preoperative assessment, including imaging to identify the target peripheral nerve. Under local anesthesia, a thin, insulated electrode is implanted near the nerve, usually with the help of fluoroscopic or ultrasound guidance for precision.

Peripheral nerve stimulation for lower-limb prosthesisPeripheral nerve stimulation for upper-limb prosthesis

Spinal Cord Stimulation (SCS) is a neuromodulation that involves the implantation of a device that delivers electrical impulses to the spinal cord through an electrode placed in the epidural space. The stimulation alters pain signals before they reach the brain, effectively masking or reducing the sensation of pain.

Spinal cord stimulation for lower-limb prosthesisSpinal cord stimulation for upper-limb prosthesis

Dorsal Root Ganglion Stimulation (DRGS) is a targeted neuromodulation technique for managing chronic pain. The procedure begins with a thorough preoperative assessment, including imaging to locate the specific dorsal root ganglion (DRG) associated with the pain. Under local anesthesia, a small electrode is implanted near the DRG. This is done through a minimally invasive procedure, often guided by fluoroscopy or CT imaging to ensure precise placement.

Dorsal root ganglion stimulation for upper-limb prosthesisExperimental: Dorsal root ganglion stimulation for lower-limb prosthesis

Motor Cortex Stimulation (MCS) is a neuromodulation technique that involves the surgical implantation of electrodes over the motor cortex, typically targeting the precentral gyrus, to deliver electrical stimulation. The procedure involves placing an electrode grid or strip on the dura mater overlying the motor cortex, which is identified via neuroimaging techniques such as functional MRI or neuronavigation. Once implanted, the electrodes are connected to an implanted pulse generator (IPG), which delivers adjustable electrical impulses.

Motor Cortex Stimulation for lower-limb prosthesisMotor Cortex Stimulation for upper-limb prosthesis

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Amputation of the upper limb at the level of the forearm or upper arm, or amputation of the lower limb at the level of the lower leg or thigh.
  • Age between 18 and 65 years.
  • Duration since amputation is at least 6 months.
  • Presence of persistent chronic pain syndrome rated between 4 and 10 on the Visual Analog Scale (VAS).
  • Absence of pregnancy at the time of implantation, confirmed by a pregnancy test (for female participants only).
  • Signed consent to participate in the study.

You may not qualify if:

  • Presence of severe somatic pathology that hinders surgical treatment and participation in the study.
  • Presence of psychiatric disorders (including a history of), severe depression, suicidal tendencies, or a history of suicide attempts.
  • Presence of severe orthopedic deformity in the limb above the level of amputation.
  • History of cancer.
  • History of epilepsy.
  • Complicated traumatic brain injury (TBI) or a history of stroke.
  • Inability to undergo electrostimulation due to other somatic pathology.
  • Purulent-septic pathology.
  • Drug addiction (including a history of).
  • Congenital anomaly of upper limb development.
  • Anomalies in the development of the central and peripheral nervous systems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency of Russia

Moscow, 117997, Russia

RECRUITING

Far Eastern Federal University

Moscow, 690922, Russia

RECRUITING

MeSH Terms

Conditions

Phantom LimbNeuralgiaChronic Pain

Interventions

Spinal Cord Stimulation

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPain, PostoperativePostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsPainPeripheral Nervous System DiseasesNeuromuscular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitation

Central Study Contacts

Yury Matvienko

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 13, 2024

First Posted

November 25, 2024

Study Start

December 1, 2024

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

May 1, 2029

Last Updated

November 25, 2024

Record last verified: 2024-11

Locations